How to Make Your Clinical Trial the Trial of Choice: When You Want to Get to Market Faster, Meeting Every Milestone Matters.

By: Reverba Clinical Partnerships Team From first patient/first dose to data lock, everything depends on recruiting and retaining clinical trial participants. That can be quite challenging. A 2022 editorial in Clinical Trials Arena noted that the biggest reason for trial termination is low accrual rates which have accounted for 25.4% of all terminated trials. The good…

Read More

Clinical Trials Day: May 20th

Today is Clinical Trials Day –a day where clinical trial awareness is raised and we honor clinical research professionals across the globe. In tribute, we are pleased to showcase a recent article in MedCityNews where a Health Stories Project® research study was cited, revealing that 97% of patients believe that their voice is key for…

Read More

Reverba Completes Acquisition of Six Degrees Worldwide to Unite Science and the Patient Voice to Advance Healthcare

SEATTLE, WA – Reverba, renowned for its innovative patient engagement solutions for biopharmaceutical companies, today announced the acquisition of Six Degrees Worldwide Inc., a leader in medical communications within the same industry. The acquisition is poised to help Reverba and its clients continue to bridge the gap between science and real-life patient experiences. Reverba’s acquisition will…

Read More

HBA Rising Star: Crystal Anderson

By: Cheryl Lubbert We’re thrilled to announce the Healthcare Businesswomen’s Association (HBA) recently named Crystal Anderson, MPH, VP, Client Partner Lead as one of its 2024 Rising Stars. Crystal joins a noteworthy group of healthcare professionals recognized for their leadership and significant contributions to their organization – all in the first 15 to 20 years…

Read More

Knock Down Internal Silos and Add More Value To The Patient Voice

A man and a woman in business attire looking at a laptop screen

By:  Jean McCoy EVP  Reverba Partnerships When it comes to listening to patients, clinical and consumer marketing tends to remain in separate silos. But incorporating the patient voice can make a positive impact at every point from pre-clinical development through commercialization and post-marketing. Doing so can help companies align their goals and programs with patients’…

Read More

Reverba: Amplifying Patient Voices In Healthcare

Healthcare Business Review magazine's cover story of Reverba

Published in Healthcare Business Review By: Cheryl Lubbert, Co-Founder and CEO While patient-focused drug development (PFDD) is the aspirational goal for every pharmaceutical company, achieving it is often more complex than anticipated. The main reason is many pharma companies view PFDD as a technological maneuver when rolling out patient engagement initiatives. Fully adopting it necessitates a…

Read More

Reverba CEO and Co-Founder Cheryl Lubbert Wins 2023 Silver Stevie® Award for Women in Business

The Stevie Awards for Women in Business - Mentor or Coach of the Year - Cheryl Lubbert

– Awards recognize female entrepreneurs, executives and employees who are making positive contributions to their workplace and to the greater community – SEATTLE, WA, Nov. 13, 2023 – Reverba, a leading global patient engagement company, today announced that Cheryl Lubbert, Chief Executive Officer, has won the Silver Stevie® Award for Women in Business in the Mentor of the Year…

Read More

Reverba Co-Founder and CEO Cheryl Lubbert named Women Leaders in Business Gold Globee® Winner

Globee Business Awards - Women Leaders in Business Winner Cheryl Lubbert

– Awards recognize individuals and women-led organizations who have demonstrated extraordinary dedication and innovation – SEATTLE – October 18, 2023 – Reverba, a leading global patient engagement company, today announced that Cheryl Lubbert, Co-Founder and CEO, has been recognized as a Women Leaders in Business Gold Globee® Winner, for her contributions and role in creating…

Read More